Second-Generation Antipsychotics for the Treatment of Disruptive Behaviour Disorders in Children: A Systematic Review

Pringsheim, Tamara; Gorman, Daniel A.

doi:10.1177/070674371205701203

Cited by 37 publications

(31 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, there are a few evidences from controlled studies that support the use of newer antipsychotics for behavioral conditions such as ADHD (7). The most atypical antipsychotics examined in children with ADHD or conduct disorder is Risperidone (8). In many studies, ADHD was associated with different diagnoses like mental retardation, oppositional defiant disorder, bipolar mood disorder and tic disorder.…”

Section: Introductionmentioning

confidence: 99%

A Comparative Study of Risperidone and Aripiprazole in Attention Deficit Hyperactivity Disorder in Children Under Six Years Old: A Randomized Double-Blind Study

et al. 2018

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

A Comparative Study of Risperidone and Aripiprazole in Attention Deficit Hyperactivity Disorder in Children Under Six Years Old: A Randomized Double-Blind Study

et al. 2018

View full text Add to dashboard Cite

show abstract

“…In case of challenging behaviours in general, prescription of neuroleptics, particularly second generation antipsychotics, has been demonstrated to be only marginally effective [98,99]. It should be stressed that such treatments are regularly accompanied by unwanted side effects especially significant weight gain and the development over time of dislipidemia and/or diabetes mellitus, subsumed under the term metabolic syndrome [100,101].…”

Section: Discussionmentioning

confidence: 99%

Aetiology Based Diagnosis and Treatment Selection in Intellectually Disabled People with Challenging Behaviours

Verhoeven¹,

Egger

2014

J. Intellect. Disabl. Diagn. Treat.

View full text Add to dashboard Cite

Since both intellectual disability and challenging behaviour are entities encompassing heterogeneous clinical conditions and current taxonomies are of limited use in this field of psychiatry, diagnosing psychiatric symptoms in intellectually disabled patients is still very complex. In the diagnostic process of psychiatric symptoms and behavioural abnormalities, the first step should be genome profiling using the latest techniques in order to detect pathogenic CNVs or single gene mutations that are causative for the developmental delay. Their importance can be derived from the scientific observation that several genetic syndromes are associated with a specific behavioural, psychiatric, neuropsychological or neurological symptom profile, relevant for both choice of treatment and prognosis. Second, it has to be stressed that psychiatric disorders, especially from the depression and anxiety spectrum, frequently manifest with atypical symptoms that may hamper adequate pharmacological treatment. With respect to challenging behaviours in general, it should be emphasized that these are essentially dependent on contextual variables for which no rational pharmacological treatment is available and behavioural interventions are primarily warranted. Prescription of psychotropics has been demonstrated to be marginally effective only and to induce regularly unwanted side effects or even an increase of abnormal behaviours. It is therefore recommended to measure always the plasma concentration of psychotropics and antiepileptics and to perform, preferably prior to the start of treatment, genotyping of relevant cytochrome isoenzymes.In is concluded that, apart from the a priori genetic analysis, careful investigation of the here described data sources is needed to formulate a diagnostic hypothesis and treatment proposal.

show abstract

“…Quoique très utilisés, les antidé presseurs ne sont pas recommandés en première instance pour la dépression ou l'anxiété chez les adolescents ou les enfants, mais peuvent être utilisés dans certaines conditions (Sparks et Duncan, 2013). Au Canada, les antipsychotiques sont utilisés relativement souvent pour les troubles de comportement, bien que les données probantes au sujet de leur efficacité soient encore limitées et que les risques associés à leurs effets métaboliques importants invitent à leur préférer des interventions psychosociales reconnues (Olfson, 2012 ;Pringsheim et Gorman, 2012). Les psychostimulants sont reconnus efficaces dans le traitement du TDAH (Brault, 2012 ;Pliszka, Carlson et Swanson, 1999), bien qu'un traitement multimodal soit recommandé parce qu'il donne des résultats supérieurs (Molina et al, 2009).…”

Section: Quand Et Comment Intervenir ?unclassified

La santé mentale jeunesse : un domaine à la croisée des chemins

Rousseau

Nadeau

Pontbriand

et al. 2014

smq

View full text Add to dashboard Cite

Si l’importance grandissante de la santé mentale des jeunes fait consensus, de multiples questionnements émergent cependant quant aux spécificités de ce domaine, qui ne peut être conçu comme une extension des services adultes pour des groupes plus jeunes. Cet article aborde ces questionnements en croisant les savoirs provenant de la documentation et ceux qui émergent à la suite de l’implantation du Plan d’action en santé mentale au Québec.Le Plan d’action en santé mentale a mis de l’avant la collaboration et le partenariat entre institutions et disciplines. Malgré des avancées significatives, des discontinuités peu favorables à une prise en charge écosystémique persistent. Un ensemble de recherches récentes suggère que les contextes organisationnels qui encadrent les services influencent à la fois la façon dont les interventions sont mises en place et leurs résultats cliniques. Une structure de gestion flexible qui engage les intervenants en favorisant une appropriation du pouvoir, tout en minimisant les sources de stress au travail et en facilitant la création de partenariats, semble nécessaire pour favoriser la concertation interdisciplinaire et intersectorielle. Celle-ci est essentielle à la mise en place de services en santé mentale jeunesse.The importance of children and youth mental health is increasingly recognized. This rapidly developing field cannot be conceptualized as an extension of adult services to a younger age group and its developmental and organizational specificities are the object of debate. Reviewing recent literature in this domain and some preliminary information about the Quebec Mental Health Plan implementation, this paper addresses some of the questions which structure this debate in Quebec.Quebec mental health plan has put at the forefront collaboration among disciplines and partnership among institutions. In spite of having produced significant improvement in the field, discontinuities in services, which interfere with an ecosystemic model of care, persist. Recent studies suggest that the organisational climate which surrounds youth mental health services has a direct impact on the quality of services and on youth health outcomes. A flexible management structure, which engages clinicians and health workers, favors empowerment, minimizes work stress and facilitates partnership, is needed to foster successful interdisciplinary and intersectorial collaboration. This collaboration is the cornerstone of youth mental health services

show abstract

Second-Generation Antipsychotics for the Treatment of Disruptive Behaviour Disorders in Children: A Systematic Review

Cited by 37 publications

References 29 publications

A Comparative Study of Risperidone and Aripiprazole in Attention Deficit Hyperactivity Disorder in Children Under Six Years Old: A Randomized Double-Blind Study

A Comparative Study of Risperidone and Aripiprazole in Attention Deficit Hyperactivity Disorder in Children Under Six Years Old: A Randomized Double-Blind Study

Aetiology Based Diagnosis and Treatment Selection in Intellectually Disabled People with Challenging Behaviours

La santé mentale jeunesse : un domaine à la croisée des chemins

Contact Info

Product

Resources

About